Nowhere is the potential for better, faster healthcare offered by wireless devices more welcome than in critical care environments. As hospital information technology departments start taking advantage of the speed, mobility, and flexibility of
Nowhere is the potential for better, faster healthcare offered by wireless devices more welcome than in critical care environments.
As hospital information technology departments start taking advantage of the speed, mobility, and flexibility of handheld wireless computing technologies, caregivers have begun using computer information obtained at bedside to make more accurate and efficient treatment decisions.
Handheld devices are superior to manual data collection and entry for quality improvement projects in medical intensive care units, according to a study presented at CHEST 2001, this week's meeting of the American College of Chest Physicians in Philadelphia.
Researchers found the use of a handheld device simplifies data collection, eliminates manual data entry, and provides prompt availability of information -- on ICU practice patterns, protocol compliance, drug utilization, and ventilator days -- that facilitates process improvement.
"This study demonstrates that use of a handheld device, or PDA (personal data assistant), is a superior alternative to manual data collection and entry in a medical intensive care unit, especially in hospitals that lack sophisticated information systems," said Dr. Barry Fuchs, medical director of the medical ICU at the University of Pennsylvania Medical Center in Philadelphia.
In cases in which data entry requires professional judgment, use of a handheld device or PDA allows the clinician to input data while participating in routine patient-care duties, such as rounds, he said.
"Measuring the effectiveness of quality initiatives for process improvement in critical care units is difficult," Fuchs said.
Typically, this process involves retrospective medical record review and/or hospital database queries unless an electronic medical record or sophisticated ICU information system is available, he said. This approach has several limitations:
According to the Fuchs study, data collection using wireless devices offers several potential improvements:
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.